XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details) - Schedule of changes in options outstanding - Options [Member]
6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Stockholders' Equity (Details) - Schedule of changes in options outstanding [Line Items]  
Number of Options, Outstanding and expected to vest, Beginning balance | shares 3,615,602
Weighted Average Exercise Price Per Share, Outstanding and expected to vest - Beginning balance | $ / shares $ 19.96
Weighted Average Remaining Contractual Term (Years), Beginning Outstanding 9 years 73 days
Aggregate Intrinsic Value, Outstanding and expected to vest - Beginning balance | $ $ 74,837,043
Number of Options, Granted | shares 850,000
Weighted Average Exercise Price Per Share, Granted | $ / shares $ 39.60
Weighted Average Remaining Contractual Term (Years), Granted 9 years 277 days
Aggregate Intrinsic Value, Outstanding and expected to vest, Granted | $ $ 4,751,500
Number of Options, Exercised | shares (115,715)
Weighted Average Exercise Price Per Share, Exercised | $ / shares $ 4.59
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Outstanding and expected to vest, Exercised | $
Number of Options, Forfeited | shares (215,312)
Weighted Average Exercise Price Per Share, Forfeited | $ / shares $ 21.58
Weighted Average Remaining Contractual Term (Years), Forfeited
Aggregate Intrinsic Value, Outstanding and expected to vest, Forfeited | $
Number of Options, Outstanding and expected to vest, Ending balance | shares 4,134,575
Weighted Average Exercise Price Per Share, Outstanding and expected to vest - Ending balance | $ / shares $ 24.35
Weighted Average Remaining Contractual Term (Years), Ending Outstanding 8 years 328 days
Aggregate Intrinsic Value, Outstanding and expected to vest - Ending balance | $ $ 84,841,303
Number of Options, Options exercisable | shares 914,103
Weighted Average Exercise Price Per Share, Options exercisable | $ / shares $ 11.82
Weighted Average Remaining Contractual Term (Years), Options exercisable 7 years 284 days
Aggregate Intrinsic Value, Options exercisable | $ $ 30,202,021